← Back
Data updated: Mar 10, 2026
ULTRATAB LABS INC
Pharmaceuticals
ULTRATAB LABS INC is a generic drug manufacturer with 1 FDA-approved products.
2020
Since
1
Drugs
-
Trials
47
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
IBUPROFEN 2025-04-29
Manufacturing (CMC)
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-04-01
Labeling
IBUPROFEN 2025-03-20
Manufacturing (CMC)
IBUPROFEN 2024-11-21
Labeling
IBUPROFEN 2024-11-21
Labeling
IBUPROFEN 2024-11-21
Labeling
IBUPROFEN 2024-11-21
Labeling
IBUPROFEN 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-01-06
- Latest
- 2020-01-06
- Applications
- 1